Skip to main content
SpringerLink
Log in

Sepsis alters pyruvate dehydrogenase kinase activity in skeletal muscle

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Chronic sepsis promotes a stable increase in pyruvate dehydrogenase kinase (PDHK) activity in skeletal muscle. PDHK is found tightly bound to the pyruvate dehydrogenase (PDH) complex and as free kinase. We investigated the ability of sepsis to modify the activity of the PDHK intrinsic to the PDH and free PDHK. Sepsis was induced by the intraabdominal introduction of a fecal-agar pellet infected with E. coli and B. fragilis. Five days later, mitochondria were isolated from skeletal muscle and PDHK measured in mitochondrial extracts. Sepsis caused an approximate 2-fold stimulation of PDHK. The mitochondrial extracts from control and septic rats were fractionated by gel chromatography on Sephacryl S-300 to separate PDHK intrinsic to PDH complex and free PDHK. PDH complex eluted at void volume and was assayed for PDHK intrinsic to the complex. The activity of PDHK intrinsic to PDH complex was a significantly increased 3 fold during sepsis. Free PDHK activity eluted after the PDH complex and its activity was enhanced by 70% during sepsis. Incubation of PDHK intrinsic to PDH with dichloroactate, an uncompetitive inhibitor of PDHK, showed the PDHK from septic rats relatively less sensitive to inhibition than controls. These results indicate that sepsis induces stable changes in PDHK in skeletal muscle.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cerra FB: Hypermetabolism-organ failure syndrome: A metabolic response to injury. Crit Care Clin 5: 289–301, 1989

    PubMed  Google Scholar 

  2. Vary TC, Siegel JH, Rivikind A: Clinical and therapeutic significance of metabolic patterns of lactic acidosis. Perspect Crit Care 1: 85–132, 1988

    Google Scholar 

  3. Cerra FB: Metabolic manifestations of multiple organ failure. Crit Care Clin 5: 119–131, 1989

    PubMed  Google Scholar 

  4. Siegel JH, Rivikind AI, Dalal S, Goodari S: Early physiologic predictors of injury and death in blunt multiple trauma. Arch Surg 125: 498–508, 1990

    PubMed  Google Scholar 

  5. Wilmore DW, Goodwin CW, Aulick LH, Powanda AC, Mason AD, Pruit BA: Effect of injury and infection on visceral metabolism and circulation. Ann Surg 192: 491–504, 1980

    PubMed  Google Scholar 

  6. Dahn MS, Lange P, Lobell K, Hans B, Jacobs LA, Mitchell RA: Splanchnic and total oxygen consumption differences in septic and injured patients. Surgery 101: 69–80, 1987

    PubMed  Google Scholar 

  7. Vary TC, Siegel JH, Zechnich A, Tall BD, Morris JG, Placko R, Jawor D: Pharmacological reversal of abnormal glucose regulation, BCAA utilization, and muscle catabolism by dichloroacetate. J Trauma 28: 1301–1311, 1988

    PubMed  Google Scholar 

  8. Lang CH, Bagby GJ, Blakesley HL, Spitzer JJ: Glucose kinetics and pyruvate dehydrogenase activity in septic rats treated with dichlororacetate. Circ Shock 7: 13–21, 1987

    Google Scholar 

  9. Vary TC, Dardevet D, Obled C, Pouyet C, Breullie D, Grizard J: Modulation of skeletal muscle lactate metabolism following bacteremia by insulin or insulin-like growth factor-I: Effects of pentoxifylline. Shock 7: 432–438, 1997

    PubMed  Google Scholar 

  10. Romanosky AJ, Bagby GL, Bockman L, Spitzer JJ: Increased muscle glucose uptake and lactate release after endotoxin administration. Am J Physiol 239: E311–E316, 1981

    Google Scholar 

  11. Curtis SE, Cain SM: Regional and systemic oxygen delivery/uptake relations and lactate flux in hyperdynamic, endotoxin-treated dogs. Ann Rev Respir Dis 145: 348–358, 1992

    Google Scholar 

  12. Bagby GJ, Lang CH, Giamo ME, Spitzer JJ: Increased glucose metabolism by epitrochlearis muscle removed from endotoxin-treated rats. Circ Shock 20: 171–179, 1986

    PubMed  Google Scholar 

  13. Vary TC, Drnevich D, Jurasinski C, Brennan WA: Mechanisms regulating skeletal muscle glucose metabolism in sepsis. Shock 3: 403–410, 1995

    PubMed  Google Scholar 

  14. Vary TC: Amrinone prevents the inhibition of muscle pyruvate dehydrogenase complex activity during sepsis. Shock 5: 229–232, 1996

    PubMed  Google Scholar 

  15. Vary TC: Sepsis-induced alterations in pyruvate dehydrogenase complex activity in rat skeletal muscle: Effects on plasma lactate. Shock 6: 89–94, 1996

    PubMed  Google Scholar 

  16. Vary TC, Martin LF: Potentiation of decreased pyruvate dehydrogenase activity by inflammatory stimuli in sepsis. Circ Shock 39: 299–305, 1993

    PubMed  Google Scholar 

  17. Vary TC, Siegel JH, Tall BD, Morris JG: Altered glucose regulation in sepsis revealed by partial reversal of PDH inhibition by dichloroacetate. Circ Shock 24: 3–18, 1988

    PubMed  Google Scholar 

  18. Vary TC, Murphy JM: Role of extra-splanchnic organs in the metabolic response to sepsis: Effect of insulin. Circ Shock 29: 41–57, 1989

    PubMed  Google Scholar 

  19. Vary TC: Increased pyruvate dehydrogenase kinase activity in response to sepsis. Am J Physiol 250: E669–E674, 1991

    Google Scholar 

  20. Bowker-Kinley MM, Davis WI, Wu P, Harris RA, Popov KM: Evidence for existence of tissue specific regulation of the mammalian pyruvate dehydrogenase complex. Biochem J 329: 191–196, 1998

    PubMed  Google Scholar 

  21. Wu P, Sato J, Zhao Y, Jaskiewcz J, Popov KM, Harris RA: Starvation and diabetes increase the amount of pyruvate dehydrogenase kinase isoenzyme 4 in rat heart. Biochem J 329: 197–201, 1998

    PubMed  Google Scholar 

  22. Kerbey AL, Richardson LJ, Randle PJ: The roles of intrinsic kinase and of kinase/activator protein in the enhanced phosphorylation of pyruvate dehydrogenase complex in starvation. FEBS Lett 176: 115–119, 1984

    PubMed  Google Scholar 

  23. Mistry SC, Priestman DA, Kerbey AL, Randle PJ: Evidence that rat liver pyruvate dehydrogenase kinase activator protein is a pyruvate dehydrogenase kinase. Biochem J 275: 775–779, 1991

    PubMed  Google Scholar 

  24. Jones BS, Yeaman SJ: Long-term regulation of pyruvate dehydrogenase complex: Evidence that kinase-activator protein (KAP) is free pyruvate dehydrogenase kinase. Biochem J 275: 781–784, 1991

    PubMed  Google Scholar 

  25. Presitman DA, Mistry SC, Kerbey AL, Randle PJ: Purification and partial characterization of rat liver pyruvate dehydrogenase kinase activator protein (free pyruvate dehydrogenase kinase). FEBS Lett 308: 83–86, 1992

    PubMed  Google Scholar 

  26. Vary TC, Siegel JH, Nakatani T, Sato T, Aoyama H: Effect of sepsis on the activity of the pyruvate dehydrogenase complex in skeletal muscle and liver. Am J Physiol 250: E634–E640, 1986

    PubMed  Google Scholar 

  27. Fuller SJ, Randle PJ: Reversible phosphorylation of pyruvate dehydrogenase in rat skeletal muscle mitochondria: Effects of starvation and diabetes. Biochem J 219: 635–646, 1984

    PubMed  Google Scholar 

  28. Kerbey AL, Randle PJ, Cooper RH, Whitehouse S, Pask HT, Denton RM: Regulation of pyruvate dehydrogenase in rat heart. Biochem J 219: 635–646, 1976

    Google Scholar 

  29. Fantania HR, Vary TC, Randle PJ: Modulation of PDH kinase activity in cultured hepatocytes by glucagon and n-octanoate. Biochem J 234: 235–236, 1986

    Google Scholar 

  30. Whitehouse S, Copper RH, Randle PJ: Mechanism of action of pyruvate dehydrogenase by dichloroacetate and other halogenated carboxylic acids. Biochem J 141: 761–774, 1974

    PubMed  Google Scholar 

  31. Priestman DA, Mistry SC, Halsall A, Randle PJ: Role of protein synthesis and of fatty acid metabolism in the longer-term regulation of pyruvate dehydrogenase kinase. Biochem J 300: 659–664, 1994

    PubMed  Google Scholar 

  32. Sugden MC, Fryer LG, Orfali KA, Priestman DA, Donald E, Holness MJ: Studies of the long-term regulation of hepatic pyruvate dehydrogenase kinase. Biochem J 329: 89–94, 1998

    PubMed  Google Scholar 

  33. Vary TC, Placko R, Siegel JH: Pharmacologic modulation of increased release of gluconeogenic precursors from extra-splanchnic organs during sepsis. Circ Shock 29: 58–76, 1989

    Google Scholar 

  34. Vary TC, Siegel JC, Placko R, Tall BD, Morris JG: Effect of dichloroacetate on plasma and hepatic amino acids in sterile inflammation and sepsis. Arch Surg 124: 1071–1077, 1989

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cellular and Molecular Physiology, Penn State University College of Medicine, Milton S. Hershey Medical Center, Hershey, PA, 17033, USA

    Thomas C. Vary

  2. Department of Biology, Lebanon Valley College, Annville, PA, 17003, USA

    Stacy Hazen

Authors
  1. Thomas C. Vary
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stacy Hazen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vary, T.C., Hazen, S. Sepsis alters pyruvate dehydrogenase kinase activity in skeletal muscle. Mol Cell Biochem 198, 113–118 (1999). https://doi.org/10.1023/A:1006993910781

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006993910781

Search

Navigation